FR2122325A2 - Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines - Google Patents

Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines

Info

Publication number
FR2122325A2
FR2122325A2 FR7101815A FR7101815A FR2122325A2 FR 2122325 A2 FR2122325 A2 FR 2122325A2 FR 7101815 A FR7101815 A FR 7101815A FR 7101815 A FR7101815 A FR 7101815A FR 2122325 A2 FR2122325 A2 FR 2122325A2
Authority
FR
France
Prior art keywords
polynucleic acid
potentiating
polycationic compounds
antiviral vaccines
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7101815A
Other languages
English (en)
French (fr)
Other versions
FR2122325B2 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAES ROLAND BE
Original Assignee
MAES ROLAND BE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAES ROLAND BE filed Critical MAES ROLAND BE
Priority to FR7101815A priority Critical patent/FR2122325A2/fr
Publication of FR2122325A2 publication Critical patent/FR2122325A2/fr
Application granted granted Critical
Publication of FR2122325B2 publication Critical patent/FR2122325B2/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55561—CpG containing adjuvants; Oligonucleotide containing adjuvants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7101815A 1971-01-20 1971-01-20 Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines Granted FR2122325A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7101815A FR2122325A2 (en) 1971-01-20 1971-01-20 Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7101815A FR2122325A2 (en) 1971-01-20 1971-01-20 Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines

Publications (2)

Publication Number Publication Date
FR2122325A2 true FR2122325A2 (en) 1972-09-01
FR2122325B2 FR2122325B2 (enExample) 1974-08-23

Family

ID=9070579

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7101815A Granted FR2122325A2 (en) 1971-01-20 1971-01-20 Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines

Country Status (1)

Country Link
FR (1) FR2122325A2 (enExample)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2328479A1 (fr) * 1975-10-22 1977-05-20 Beecham Group Ltd Substance antivirale
EP0009498A4 (en) * 1978-01-16 1980-10-16 Univ Boston DELIVERY OF CELLULAR RECORDING OF MOLECULES.
WO1996021036A3 (en) * 1994-12-30 1996-09-06 Viagene Inc Nucleic acid condensing agents with reduced immunogenicity

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2328479A1 (fr) * 1975-10-22 1977-05-20 Beecham Group Ltd Substance antivirale
EP0009498A4 (en) * 1978-01-16 1980-10-16 Univ Boston DELIVERY OF CELLULAR RECORDING OF MOLECULES.
WO1996021036A3 (en) * 1994-12-30 1996-09-06 Viagene Inc Nucleic acid condensing agents with reduced immunogenicity

Also Published As

Publication number Publication date
FR2122325B2 (enExample) 1974-08-23

Similar Documents

Publication Publication Date Title
IE37187L (en) Immunological adjunants for vaccines
NL178013B (nl) Werkwijze voor het bereiden van een celvrije herpesvirussuspensie of een gevriesdroogd produkt daarvan, alsmede een werkwijze voor het bereiden van een vaccin uit een aldus verkregen suspensie of produkt.
NL153178B (nl) Werkwijze voor het bereiden van een preparaat met een insekten bestrijdende werking, gevormd preparaat en werkwijze voor het bereiden van dieenzuurderivaten.
NL178967B (nl) Werkwijze voor het bereiden van een geneesmiddel met antihyperlipidemische werking en van een daarvoor geschikt alkoxyarylcarbonzuur.
NL7601455A (nl) Werkwijze ter bereiding van prostaglandine-analo- ga; werkwijze ter bereiding van farmaceutische preparaten, alsmede gevormde voortbrengselen.
IT967745B (it) Sistema per convogliare documenti in modo controllato
IE37602L (en) Cyclocpentane derivatives
FI50139C (fi) Menetelmä molekyylipainoltaan ja saannoltaan säädettävän pullulaanin v almistamiseksi
CA927842A (en) Oil-soluble aliphatic acid modified high molecular weight mannich condensation products
IT1059134B (it) Sistema per la movimentazione del la posta utilizzante dei documenti di formati o di nature diverse
FR2122325A2 (en) Polynucleic acid/polycationic compounds - for potentiating antiviral vaccines
BE787928A (fr) Procede ameliore de preparation de polyamides a poids moleculaire elev
NL168210B (nl) Werkwijze ter bereiding van farmaceutische preparaten, alsmede werkwijze ter bereiding van cyclische carbon- zuurderivaten.
GB1461188A (en) Live influenza virus vaccines and preparation thereof
IE36280B1 (en) Process for the industrial preparation of deoxyribonucleic acids of high molecular weight
IT992027B (it) Processo e dispositivo per la steri lizzazione di contenitori per prepa rati farmaceutici mediante fiamma tura
GB1252092A (enExample)
BE777369A (fr) Vaccin contre la gourme equine et procede de sa preparation
NL167411C (nl) Werkwijze voor het bereiden van allylesters van carbon- zuren uit propeen, zuurstof en carbonzuur.
FR2274526A1 (fr) Dispositif d'aiguillage pour convoyeur de lettres, plis postaux ou autres objets minces
IT1048969B (it) Procedimento per la produzione di proteine solubili e relativo prodotto
IE35357B1 (en) Process for preparing n-alkyl-dimethylamines
SU511743A1 (ru) Способ получени ассоциированной вакцины
Kuroda Distribution of the anserine birds found in the Japanese Islands. I
NL7411058A (nl) Werkwijze voor het bereiden van hoger molecu- laire, alifatische carbonzuren.

Legal Events

Date Code Title Description
TP Transmission of property
GC Lien (pledge) constituted